NCT01704287
- Conditions
- Malignant Melanoma, Melanoma, Neoplasms, +11 more
- Locations
-
Not specified
Clinical trial condition
Neuroendocrine Tumors
Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.
2,773 public trials
496 recruiting studies
Neuroendocrine Tumors trial results
NCT00066404
- Conditions
- Adenocarcinoma, Adenoma, Adnexal Diseases, +114 more
- Locations
-
- Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States
NCT01880749
- Conditions
- Central Nervous System Neoplasms, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, +34 more
- Locations
-
- New York University School of Medicine New York, United States
Completed
Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies
NCT02223052
- Conditions
- Acute Myeloid Leukemia, Adenocarcinoma, Adnexal Diseases, +106 more
- Locations
-
- Scottsdale Healthcare Research Institute Scottsdale, Arizona, United States
- Mayo Clinic - Arizona Scottsdale, Arizona, United States
- University of Arizona Cancer Center Tucson, Arizona, United States
- University of Iowa Iowa City, Iowa, United States
Completed
Spanish Registry of Mohs Surgery
NCT02310503
- Conditions
- Carcinoma, Carcinoma, Basal Cell, Carcinoma, Squamous Cell, +24 more
- Locations
-
- Hospital Universitario de Cruces Barakaldo, Spain
- Hospital del Mar Barcelona, Spain
- Hospital Quirón Teknon Barcelona, Spain
- Hospital Santa Creu i Sant Pau Barcelona, Spain
NCT02516527
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
- Locations
-
- Local Institution Guangzhou, Guangdong, China
NCT02431572
- Conditions
- Astrocytoma, Brain Diseases, Brain Neoplasms, +21 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
Completed
PET Imaging of Cancer Patients Using [18F]-SKI-249380, a Radiolabeled Dasatinib-Derivative
NCT01916135
- Conditions
- Carcinoma, Hemic and Lymphatic Diseases, Immune System Diseases, +21 more
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States
Completed
Recombinant Human Arginase 1 (rhArg1) in Patients With Advanced Arginine Auxotrophic Solid Tumors
NCT02285101
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
- Locations
-
- California Cancer Associates for Research and Excellence, cCARE San Diego, California, United States
- John Wayne Cancer Institute Santa Monica, California, United States
NCT03002376
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
- Locations
-
- Radboud University Medical Center Nijmegen, Netherlands
- Military Medical Academy Belgrade, Serbia
- Seoul National University Hospital Seoul, South Korea
- Asan Medical Center Seoul, South Korea